Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.56%
#3 Pons Pons +32.20%
#4 Helium Helium +28.69%
#5 TENDIES TENDIES +21.80%
#6 Giggle Fund Giggle Fund +20.11%
#7 OpenGradient OpenGradient +19.68%
#8 Prom Prom +18.47%
#9 龙虾 (Lobster) 龙虾 (Lobster) +17.88%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Corvus Pharmaceuticals, Inc. Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.

CRVS
Rankning i aktier #8729
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm specializing in the development and commercialization of immuno-oncology therapies. Their leading investigational compound, Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, is currently progressing through Phase Ib/II clinical trials for the treatment of non-small cell lung cancer and head and neck cancers. Another promising candidate, CPI-818, functions as a covalent ITK inhibitor. This therapy is undergoing Phase I/Ib clinical evaluation for patients battling various malignant T-cell lymphomas, aiming to impede the proliferation of specific malignant T-cells. Additionally, Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor, is in Phase II clinical trials for individuals diagnosed with either advanced or refractory renal cell carcinoma. Beyond these clinical-stage assets, Corvus maintains a preclinical portfolio including CPI-182, an antibody designed to block inflammation and myeloid suppression, and CPI-935, an adenosine A2B receptor antagonist intended to prevent fibrosis. The company also benefits from a strategic collaboration with Angel Pharmaceuticals, which aids in advancing its diverse pipeline of targeted experimental drugs. Founded in 2014, Corvus Pharmaceuticals is headquartered in Burlingame, California.
Aktiekurs
$14.07
Senast synkroniserad: 2026-08-28
Marknadsvärde
$1.18B
Förändring (1 dag)
-4.41%
Förändring (1 år)
145.13%
Land
US
Handel Corvus Pharmaceuticals, Inc. (CRVS)

Kategori

Healthcare
Utdelningshistorik för Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (aktiens symbol: CRVS) har gjort totalt 0 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: 0.00
Utdelningsavkastning (TTM): 0
Utdelningsbetalningar för Corvus Pharmaceuticals, Inc. (CRVS) från 2026 till 2026
Årliga utdelningsbetalningar
År Utdelning (justerat för aktiesplitar) Ändra
Inte tillräckligt med data för de angivna datumen.
Lista över alla utdelningsbetalningar
År Utdelning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningar för liknande företag eller konkurrenter
Företag Antal utdelningsbetalningar Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH